Abruptio placentae with coagulopathy: a rational basis for management

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Hematology

Background:

• Abruptio placentae, especially with fetal demise, can lead to severe maternal complications.
• Overt coagulopathy (grade IIIB) is a significant risk with fetal death (grade III) in placental abruption.
• Coagulopathy in the presence of a live fetus is uncommon but indicates a grave prognosis.

Purpose of the Study:

• To outline the management of abruptio placentae complicated by overt coagulopathy.
• To emphasize the importance of timely delivery in managing maternal complications.
• To discuss therapeutic options, including aprotinin and surgical interventions.

Main Methods:

• Review of clinical presentation and management strategies for abruptio placentae with coagulopathy.
• Discussion of the role of rapid vaginal delivery and cesarean section.
• Consideration of adjunctive therapies like aprotinin and management of postpartum complications.

Main Results:

• Rapid, atraumatic vaginal delivery is the primary treatment for abruptio placentae with overt coagulopathy.
• Spontaneous reversal of coagulopathy is expected after delivery.
• Aprotinin may limit disseminated intravascular coagulation (DIC) and facilitate delivery, but is not available in the US.
• Cesarean section is indicated for uterine inertia if aprotinin is unavailable.

Conclusions:

• Prompt delivery is crucial for improving maternal prognosis in abruptio placentae with coagulopathy.
• Management requires vigilance for postpartum hemorrhage and other potential complications like renal failure.
• Timely intervention, including cesarean section when necessary, is vital when advanced therapies are unavailable.